7Baggers
 published on: 2025-09-30 05:59:24  newser.com Tue, 30 Sep 2025 10:59:24 GMT
 published on: 2025-09-29 00:44:18  newser.com Mon, 29 Sep 2025 05:44:18 GMT
 Published on: 2025-09-29 00:01:37  newser.com Mon, 29 Sep 2025 05:01:37 GMT
 published on: 2025-09-15 18:31:07  newser.com Mon, 15 Sep 2025 23:31:07 GMT
 slotnik capital llc cuts stake in inhibrx biosciences, inc. $inbx  MarketBeat Mon, 15 Sep 2025 09:29:33 GMT
 slotnik capital llc cuts stake in inhibrx biosciences, inc. $inbx  MarketBeat Sun, 14 Sep 2025 07:00:00 GMT
 published on: 2025-09-14 01:47:46  newser.com Sun, 14 Sep 2025 06:47:46 GMT
 published on: 2025-09-13 21:10:05  newser.com Sun, 14 Sep 2025 02:10:05 GMT
 published on: 2025-09-13 16:37:05  newser.com Sat, 13 Sep 2025 21:37:05 GMT
 nuveen llc invests $350,000 in inhibrx biosciences, inc. $inbx  MarketBeat Thu, 11 Sep 2025 07:00:00 GMT
 published on: 2025-09-09 23:05:19  Newser Wed, 10 Sep 2025 04:05:19 GMT
 nuveen llc buys shares of 25,021 inhibrx biosciences, inc. $inbx  MarketBeat Mon, 08 Sep 2025 10:44:56 GMT
 published on: 2025-09-08 04:24:22  Newser Mon, 08 Sep 2025 09:24:22 GMT
 published on: 2025-09-03 23:21:46  Newser Thu, 04 Sep 2025 04:21:46 GMT

Inhibrx, Inc
(NASDAQ:INBX) 

INBX stock logo

Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. Its therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 1 clinical trials in patients with solid tumors, including sarc...

Founded: 2010
Full Time Employees: 75
CEO: Mark P. Lappe  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends